Publications by authors named "N Valveny"
Background: Cancer-related fatigue (CRF) occurs in nearly all patients with metastatic breast cancer (MBC).
Objectives: This real-world analysis aimed to describe the prevalence and importance of fatigue in patients with MBC within 3 months of treatment with single-agent taxane-based chemotherapy during the timeframe of 2020-2022 in the United States and Europe. It was also conducted to assess whether there was a difference in relapsed patients compared to patients diagnosed .
Article Synopsis
- The study emphasizes the importance of real world data (RWD) for understanding and responding to the COVID-19 pandemic using a standardized approach through the CHARYBDIS framework.
- Researchers conducted a retrospective database study across multiple countries, including the US and parts of Europe and Asia, involving over 4.5 million individuals and focusing on their clinical characteristics and outcomes.
- Findings reveal higher diagnoses among women but more hospitalizations among men, common comorbidities like diabetes and heart disease, and key symptoms such as cough and fever; this data helps to identify trends in COVID-19 across different populations and time periods.
The PERSEIDS study aimed to estimate incidence/prevalence of interstitial lung diseases (ILDs), fibrosing interstitial lung diseases (F-ILDs), idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated ILD (SSc-ILD), other non-IPF F-ILDs and their progressive-fibrosing (PF) forms in six European countries, as current data are scarce. This retrospective, two-phase study used aggregate data (2014-2018). In Phase 1, incident/prevalent cases of ILDs above were identified from clinical databases through an algorithm based on codes/keywords, and incidence/prevalence was estimated.
View Article and Find Full Text PDFObjective: To characterise patients with and without prevalent hypertension and COVID-19 and to assess adverse outcomes in both inpatients and outpatients.
Design And Setting: This is a retrospective cohort study using 15 healthcare databases (primary and secondary electronic healthcare records, insurance and national claims data) from the USA, Europe and South Korea, standardised to the Observational Medical Outcomes Partnership common data model. Data were gathered from 1 March to 31 October 2020.
Article Synopsis
- Routinely collected real-world data (RWD) is essential for understanding and responding to the COVID-19 pandemic, as demonstrated by the CHARYBDIS framework for standardizing and analyzing this data.
- A descriptive cohort study involving over 4.5 million individuals was conducted across the U.S., Europe, and Asia to examine COVID-19-related health risks and outcomes, with detailed information available on an interactive website.
- The findings from the CHARYBDIS study serve as benchmarks to enhance our knowledge of COVID-19's progression and management, facilitating timely evaluations of new preventative and therapeutic strategies.